Investor mix
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 25% |
| Other / undisclosed | 3 | 75% |
Biotechnology company developing immunotherapies for cancer and chronic viral infections
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 25% |
| Other / undisclosed | 3 | 75% |